| Megan Xuanhai Vu, | |
|
30 Pidgeon Hill Dr, Sterling, VA 20165-6130 | |
| (703) 430-4355 | |
| (703) 430-6610 |
| Full Name | Megan Xuanhai Vu |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 30 Pidgeon Hill Dr, Sterling, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205136256 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202204769 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Xuanhai Vu, 30 Pidgeon Hill Dr, Sterling, VA 20165-6130 Ph: (703) 430-4355 | Megan Xuanhai Vu, 30 Pidgeon Hill Dr, Sterling, VA 20165-6130 Ph: (703) 430-4355 |
News Archive
The memory storage molecule PKMzeta maintains long-term memories in the neocortex and its presence is continually required in order for the memory to endure, according to a finding by researchers at the Weizmann Institute in Rehovot, Israel and SUNY Downstate Medical Center in Brooklyn, New York.
The U.S. Food and Drug Administration today approved Levaquin (levofloxacin) to treat patients with plague, a rare and potentially deadly bacterial infection. The agency also approved the drug to reduce the risk of getting plague after exposure to Yersinia pestis, the bacterium that causes the disease.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2018, the launches and uptake of reformulations of conventional analgesics will drive annual three percent growth in the acute pain drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.
› Verified 9 days ago
Swapna Kodimela, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20800 Great Falls Plz, Sterling, VA 20165 Phone: 703-421-4020 | |
Mary Dohanh Weems, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21398 Price Cascades Plz, Sterling, VA 20164 Phone: 703-406-7048 | |
Ahmed Hassan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45999 Center Oak Plz Ste 120, Sterling, VA 20166 Phone: 888-818-6337 | |
Dr. Richard Logan Altizer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22370 Davis Dr Ste 190, Sterling, VA 20164 Phone: 703-434-0698 | |
Cassandra Joe-louis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 46965 Cedar Lake Plz, Sterling, VA 20164 Phone: 703-430-3328 Fax: 703-430-8203 | |
Dr. Donna Matthias, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22370 Davis Dr Ste 190, Sterling, VA 20164 Phone: 703-466-4906 | |
Mrs. Deborah A Jungling, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45940 Horseshoe Dr, Suite 150, Sterling, VA 20166 Phone: 703-406-6906 Fax: 703-406-6853 |